This episode was originally released on May 5, 2022 | In this episode of Holland & Knight Public Policy & Regulation Group's Eyes on Washington podcast series, Senior Policy Advisor Shawna Watley is joined by Tanisha D. Hill, the Senior U.S. Medical Director of the digital health portfolio of products at Teva Pharmaceuticals, and the President and Founder of the Digital Health for Equitable Health (DHEH) Alliance. DHEH is a nonprofit organization with the mission to improve access to care in underserved populations using digital health. This conversation focuses on the evolving story of digital health across sectors and technology and how the government can be involved in digital health transformation to achieve equitable healthcare in the United States. Ms. Hill shares details about the work of DHEH, the digital health space as a whole and what technologies are driving the industry forward. She also explains how community stakeholders and organizations can elevate the digital transformation of health through courageous conversations and policy advocacy.

This episode was originally released on May 2, 2022 | In this episode of Holland & Knight’s The Eyes on Washington Podcast, Public Policy & Regulation attorneys Rich Gold and Marissa Serafino discuss the on-campus interview (OCI) process. They begin the podcast by explaining what the OCI process is and how Holland & Knight's Public Policy & Regulation Group has been participating in on-campus interviews for more than 25 years. As leader of the firm's Public Policy & Regulation Group, Mr. Gold shares valuable insight on what he looks for in applicants when doing on-campus interviews. Ms. Serafino shares her experience in the OCI process and gives law school students advice on how to prepare for interviews and how to take full advantage of what the process has to offer. The podcast ends with Mr. Gold talking about his favorite interview question that surprisingly involved Betty White.

This episode was originally released on March 23, 2022 | In the fourth episode of Holland & Knight’s Eyes on Washington Podcast Special Miniseries about the National Defense Authorization Act (NDAA), attorney Dan Sennott is joined by head of the National Security, Defense and Intelligence Team Jason Klitenic. Their conversation focuses on the future of national security in the United States. They explore how foreign influences on U.S. domestic affairs have evolved over the last few years particularly through the use of technology. Mr. Klitenic highlights how foreign actors have been able to infiltrate and undermine the United States through false information, misinformation and disinformation on social media platforms. He also shares advice for combatting misinformation as a way to restore faith in American democracy. The conversation briefly touches on the Russia and Ukraine conflict, indicating the likelihood of cyber-attacks and potential ramifications on Ukraine and the rest of the world. Lastly, Mr. Sennott and Mr. Klitenic share their thoughts about security clearance reform and protection of U.S. technology from intellectual property theft.This Eyes on Washington Podcast Special Miniseries breaks down the National Defense Authorization Act (NDAA), which is the yearly authorization of funding and policy for the entire Department of Defense (DoD). Hosted by attorney Dan Sennott, this miniseries delves deep into the Fiscal Year 2022 (FY22) NDAA, its wide-reaching provisions, policy initiatives and the associated laws being passed in Congress. In each episode of this miniseries, Holland & Knight attorneys will tackle specific topics and themes in the FY22 NDAA.

This episode was originally released on March 9, 2022 | In the third episode of Holland & Knight’s Eyes on Washington Podcast Special Miniseries about the National Defense Authorization Act (NDAA), National Security attorney Dan Sennott is joined by government contracts attorneys Eric Crusius and Leila George-Wheeler. Their conversation focuses mainly on cybersecurity provisions and acquisition reform in the FY22 NDAA. The group outlines major shifts in the cybersecurity enforcement space as a result of the Cybersecurity Maturity Model Certification program (CMMC) and what implications that will have on small businesses and contractors. They also provide insight on DoD’s acquisition approach for software and innovative technologies, indicating how it has changed the landscape of the industry. Ms. George-Wheeler touches on the False Claims Act as it relates to CMMC and likely enforcement trends under the Biden Administration. Lastly, the group provides predictions for next year’s NDAA.This Eyes on Washington Podcast Special Miniseries breaks down the National Defense Authorization Act (NDAA), which is the yearly authorization of funding and policy for the entire Department of Defense (DoD). Hosted by attorney Dan Sennott, this miniseries delves deep into the Fiscal Year 2022 (FY22) NDAA, its wide-reaching provisions, policy initiatives and the associated laws being passed in Congress. In each episode of this miniseries, Holland & Knight attorneys will tackle specific topics and themes in the FY22 NDAA.

This episode was originally released on February 25, 2022 | In the second episode of Holland & Knight’s Eyes on Washington Podcast Special Miniseries about the National Defense Authorization Act (NDAA), National Security attorney Dan Sennott is joined by Public Policy attorneys Nasim Fussell and Chris DeLacy. Their conversation hones in on the economic relationship between the United States and China, its history, the current state of affairs and what’s on the horizon for the two countries. They spend time discussing a number of past and current efforts taken by U.S. government entities to address competition with China, including the CHIPS Act, which was passed via the NDAA and authorizes funding to develop the U.S. semiconductor manufacturing industrial base. The group also touches on additional legislation related to China including, the United States Innovation and Competition Act (USICA) and the America Competes Act.This Eyes on Washington Podcast Special Miniseries breaks down the National Defense Authorization Act (NDAA), which is the yearly authorization of funding and policy for the entire Department of Defense (DoD). Hosted by attorney Dan Sennott, this miniseries delves deep into the Fiscal Year 2022 (FY22) NDAA, its wide-reaching provisions, policy initiatives and the associated laws being passed in Congress. In each episode of this miniseries, Holland & Knight attorneys will tackle specific topics and themes in the FY22 NDAA.

This episode was originally released on February 22, 2022 | In the inaugural episode of Holland & Knight’s Eyes on Washington Podcast Special Miniseries about the National Defense Authorization Act (NDAA), National Security attorney Dan Sennott is joined by Public Policy attorney Marissa Serafino. Their conversation provides an overview of the NDAA and highlights general themes, including major defense and non-defense related provisions in this year’s bill. They also discuss acquisition reform, a topic consistent with bills in years past, and emerging technologies, which will continue to have a tremendous impact on the world at large.This Eyes on Washington Podcast Special Miniseries breaks down the National Defense Authorization Act (NDAA), which is the yearly authorization of funding and policy for the entire Department of Defense (DoD). Hosted by attorney Dan Sennott, this miniseries delves deep into the Fiscal Year 2022 (FY22) NDAA, its wide-reaching provisions, policy initiatives and the associated laws being passed in Congress. In each episode of this miniseries, Holland & Knight attorneys will tackle specific topics and themes in the FY22 NDAA.

This episode was originally released on December 22, 2021 | In honor of National Sickle Cell Awareness Month, Holland & Knight's Public Policy & Regulation Group is proud to partner with the Black Women's Health Imperative (BWHI) for a four-part podcast series on sickle cell disease. Sickle cell disease is a genetic disease that causes red blood cells, which are normally round, to become C-shaped like a sickle. It is a progressive and debilitating disease that can cause pain crises, organ damage and a shortened lifespan, and it disproportionately impacts communities of color, occurring in approximately one in every 365 Black or African American individuals in the United States.This episode is co-hosted by Holland & Knight Senior Policy Advisor Shawna Watley, Chief Policy Officer & Counsel for BWHI Tammy Boyd and Senior Director for Alliance Development and Government Affairs at bluebird bio Sonya Elling. They are joined by the Director of the Center for Sickle Cell Disease at Howard University, Dr. James Taylor VI, MD who shares insight about the mission and history of the center. He explains what sickle cell centers are, describes why they are so rare in the United States and illustrates how their increased existence could change the course of healthcare for people living with sickle cell. This discussion explores legislation related to sickle cell disease, including the National Sickle Cell Control Act which is celebrating its 50th anniversary next year. Dr. Taylor provides an overview of how funding for sickle cell research and clinical care has historically been distributed, highlighting the disparities in comparison to diseases like cystic fibrosis. During this episode, the group also focuses on discrepancies in care for people with sickle cell when transitioning from pediatric to adult care and how policies can work to better support adults with sickle cell.

This episode was originally released on December 14, 2021 | In In honor of National Sickle Cell Awareness Month, Holland & Knight's Public Policy & Regulation Group is proud to partner with the Black Women's Health Imperative (BWHI) for a four-part podcast series on sickle cell disease. Sickle cell disease is a genetic disease that causes red blood cells, which are normally round, to become C-shaped like a sickle. It is a progressive and debilitating disease that can cause pain crises, organ damage and a shortened lifespan, and it disproportionately impacts communities of color, occurring in approximately one in every 365 Black or African American individuals in the United States.This episode is co-hosted by Holland & Knight Senior Policy Advisor Shawna Watley, Policy Counsel for BWHI Kineta Sealey and Senior Director for Alliance Development and Government Affairs at bluebird bio Sonya Elling. They are joined by President and CEO of BWHI Linda Goler Blount. This discussion explores the mission and history of BWHI and the impact the organization has had on black women and women of color. Ms. Goler Blount, an epidemiologist, shares how her background as a scientist has allowed her to bring a different perspective to the organization and to policy discussions in the healthcare space. During this episode, the group highlights the growing healthcare disparities for those living with sickle cell disease and the role implicit racism and bias plays in the treatment of patients. Ms. Goler Blount shares insight on how policies can guarantee access and close gaps.

This episode was originally released on November 17, 2021 | In honor of National Sickle Cell Awareness Month, Holland & Knight's Public Policy & Regulation Group is proud to partner with the Black Women's Health Imperative for a four-part podcast series on sickle cell disease. Sickle cell disease is a genetic disease that causes red blood cells, which are normally round, to become C-shaped like a sickle. It is a progressive and debilitating disease that can cause pain crises, organ damage and a shortened lifespan, and it disproportionately impacts communities of color, occurring in approximately one in every 365 Black or African American individuals in the United States.This episode is co-hosted by Holland & Knight Senior Policy Advisor Shawna Watley, Chief Policy Officer & Senior Counsel for Black Women’s Health Imperative Tammy Boyd and Senior Director for Alliance Development and Government Affairs at bluebird bio Sonya Elling. They are joined by Ty Montgomery, wide receiver for the New Orleans Saints of the National Football League and returning guest Dr. Anjulika Chawla, M.D., FAAP, of bluebird bio, a Massachusetts-based company focused on developing gene and cell therapies for severe and rare genetic diseases including sickle cell. Together, they tackle the challenges of playing sports with sickle cell trait and how Ty has learned to overcome those challenges during his professional football career. This discussion also emphasizes the importance of educating the community on how to cope with the disease and how you can help by donating blood and bone marrow. Dr. Chawla also gives us a detailed explanation of the difference between sickle cell trait and sickle cell disease and gives us exciting news about the future.

This episode was originally released on November 2, 2021 | In honor of National Sickle Cell Awareness Month, Holland & Knight's Public Policy & Regulation Group is proud to partner with the Black Women's Health Imperative for a four-part podcast series on sickle cell disease. Sickle cell disease is a genetic disease that causes red blood cells, which are normally round, to become C-shaped like a sickle. It is a progressive and debilitating disease that can cause pain crises, organ damage and a shortened lifespan, and it disproportionately impacts communities of color, occurring in approximately one in every 365 Black or African American individuals in the United States.This episode is co-hosted by Holland & Knight Senior Policy Advisor Shawna Watley, Chief Policy Officer & Senior Counsel for Black Women’s Health Imperative Tammy Boyd and Senior Director for Alliance Development and Government Affairs at bluebird bio Sonya Elling. They are joined by two sickle cell warriors: Teonna Woolford, CEO of Sickle Cell Reproductive Health Education Directive (SC RED) and Phillip Okwo, an accomplished business and finance professional, sickle cell advocate and Vice Chair of SC RED's founding board. This discussion explores the journeys of both Ms. Woolford and Mr. Okwo as individuals living with sickle cell disease and how they applied their lived experiences to advocacy work in the community. They emphasize healthcare inequities facing the sickle cell community, particularly in regards to reproductive health. During this episode, the group explores current legislation and possible new policy efforts to combat these inequities and improve the overall quality of life for sickle cell warriors. They also highlight how education can play a role in advancing the quality of care for those living with sickle cell.